Stocks and Investing Stocks and Investing
Thu, June 13, 2024
Wed, June 12, 2024

Tiago Fauth Maintained (UTHR) at Buy with Increased Target to $350 on, Jun 12th, 2024


Published on 2024-10-28 11:54:34 - WOPRAI, Tiago Fauth
  Print publication without navigation


Tiago Fauth of Wells Fargo, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Increased Target from $325 to $350 on, Jun 12th, 2024.

Tiago has made no other calls on UTHR in the last 4 months.



There are 5 other peers that have a rating on UTHR. Out of the 5 peers that are also analyzing UTHR, 1 agrees with Tiago's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Increased Target to $240 on, Friday, May 3rd, 2024


These are the ratings of the 4 analyists that currently disagree with Tiago


  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $300 on, Tuesday, May 21st, 2024
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $400 on, Thursday, May 2nd, 2024
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, May 2nd, 2024
  • Liana Moussatos of "Wedbush" Reiterated at Buy and Held Target at $308 on, Thursday, February 22nd, 2024
Contributing Sources